Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru
Descripción del Articulo
ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA)...
Autores: | , , , , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2017 |
Institución: | Universidad Nacional Mayor de San Marcos |
Repositorio: | Revistas - Universidad Nacional Mayor de San Marcos |
Lenguaje: | español |
OAI Identifier: | oai:ojs.csi.unmsm:article/13222 |
Enlace del recurso: | https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222 |
Nivel de acceso: | acceso abierto |
Materia: | ABO Incompatible Trasplante Renal Acomodación Anticuerpos anti HLA Riesgo Inmunológico. ABO Incompatibility Kidney Transplantation Accommodation HLA antibodies Immunological Risk. |
id |
REVUNMSM_11108bc84bda55b62736d939bb1f3ff4 |
---|---|
oai_identifier_str |
oai:ojs.csi.unmsm:article/13222 |
network_acronym_str |
REVUNMSM |
network_name_str |
Revistas - Universidad Nacional Mayor de San Marcos |
repository_id_str |
|
spelling |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and PeruTrasplante renal grupo sanguíneo ABO incompatible. Experiencia colaborativa inédita España y PerúMéndez Chacón, PedroBardales, FernandoChunga, AusbertoMéndez Chacón, CarlaVidalón Fernández, ArmandoDiekmann, FritzOppenheimer, FedericoCampistol, Josep MaríaABO IncompatibleTrasplante RenalAcomodaciónAnticuerpos anti HLARiesgo Inmunológico.ABO IncompatibilityKidney TransplantationAccommodationHLA antibodiesImmunological Risk.ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA) 89% kidney retransplantation patient, who lacked any option to get a cadaveric or family donor. However, the patient’s sole HLA-compatible living donor had group A blood incompatible with the recipient’s O blood group. The patient required a pre-conditioning regime that consisted of plasma exchange, rituximab, immunoglobulin, and quadruple immunosuppressive therapy in order to reduce high titers of anti-A isoagglutinins from 1:128 to a safe level of 1:8, for successful transplant. This was performed in coordination with the Renal Transplant Unit of Hospital Clinic de Barcelona (HCB), Spain. Absence of rejection mediated by isoagglutinins shows the potential benefit of a protocol consisting in removing antibodies from the anti-blood group. Two years after transplantation, the kidney function remains stable, with creatinine levels of 1.5 mg%. We conclude that an ABO-incompatible kidney transplant is a viable option for patients whose only donor has blood of an incompatible blood group and for us this represents a hope-inspiring source of organs.La incompatibilidad de grupo sanguíneo ABO y la sensibilización al HLA constituyen grandes barreras a vencer en pro de la óptima utilización de riñones de donante vivo. Describimos en nuestro medio el primer trasplante renal exitoso ABO incompatible en un paciente de 24 años, retrasplantado renal, altamente sensibilizado (PRA: 89%) y sin opción alguna en disponer de donantes cadavéricos ni familiares. Sin embargo, su único donante vivo HLA compatible era de grupo sanguíneo A incompatible con el grupo O del receptor. El paciente requirió de un régimen precondicionante consistente en recambios plasmáticos, rituximab, imunoglobulina y terapia inmunosupresora cuádruple, a fin de reducir los títulos elevados de isoaglutininas anti A de 1:128 a niveles de seguridad de 1:8, para el éxito del trasplante. Este fue realizado en Coordinación con la Unidad de Trasplante Renal del Hospital Clínic de Barcelona España (HCB). La ausencia de rechazo mediado por isoaglutininas muestra el potencial beneficio del protocolo al remover los anticuerpos anti grupo sanguíneo. A los dos años del trasplante, la función renal se mantiene estable con niveles de creatinina 1,5 mg%. Concluimos que el trasplante renal ABO incompatible (ABOi) es opción viable para pacientes cuyo único donante sea grupo sanguíneo incompatible, y entre nosotros representa esperanzadora fuente de órganos.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2017-07-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1322210.15381/anales.v78i2.13222Anales de la Facultad de Medicina; Vol. 78 No. 2 (2017); 224-229Anales de la Facultad de Medicina; Vol. 78 Núm. 2 (2017); 224-2291609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222/12353Derechos de autor 2017 Pedro Méndez Chacónhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/132222017-11-21T08:48:35Z |
dc.title.none.fl_str_mv |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru Trasplante renal grupo sanguíneo ABO incompatible. Experiencia colaborativa inédita España y Perú |
title |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
spellingShingle |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru Méndez Chacón, Pedro ABO Incompatible Trasplante Renal Acomodación Anticuerpos anti HLA Riesgo Inmunológico. ABO Incompatibility Kidney Transplantation Accommodation HLA antibodies Immunological Risk. |
title_short |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
title_full |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
title_fullStr |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
title_full_unstemmed |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
title_sort |
Incompatible ABO blood group renal transplant. Unprecedented collaborative experience between Spain and Peru |
dc.creator.none.fl_str_mv |
Méndez Chacón, Pedro Bardales, Fernando Chunga, Ausberto Méndez Chacón, Carla Vidalón Fernández, Armando Diekmann, Fritz Oppenheimer, Federico Campistol, Josep María |
author |
Méndez Chacón, Pedro |
author_facet |
Méndez Chacón, Pedro Bardales, Fernando Chunga, Ausberto Méndez Chacón, Carla Vidalón Fernández, Armando Diekmann, Fritz Oppenheimer, Federico Campistol, Josep María |
author_role |
author |
author2 |
Bardales, Fernando Chunga, Ausberto Méndez Chacón, Carla Vidalón Fernández, Armando Diekmann, Fritz Oppenheimer, Federico Campistol, Josep María |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
ABO Incompatible Trasplante Renal Acomodación Anticuerpos anti HLA Riesgo Inmunológico. ABO Incompatibility Kidney Transplantation Accommodation HLA antibodies Immunological Risk. |
topic |
ABO Incompatible Trasplante Renal Acomodación Anticuerpos anti HLA Riesgo Inmunológico. ABO Incompatibility Kidney Transplantation Accommodation HLA antibodies Immunological Risk. |
description |
ABO blood group incompatibility and HLA sensitization are major barriers that need to be overcome in order to make optimum use of kidneys from living donors possible. We report the first successful ABOincompatible kidney transplant in a 24-year old, highly sensitized (panel reactive antibodies (PRA) 89% kidney retransplantation patient, who lacked any option to get a cadaveric or family donor. However, the patient’s sole HLA-compatible living donor had group A blood incompatible with the recipient’s O blood group. The patient required a pre-conditioning regime that consisted of plasma exchange, rituximab, immunoglobulin, and quadruple immunosuppressive therapy in order to reduce high titers of anti-A isoagglutinins from 1:128 to a safe level of 1:8, for successful transplant. This was performed in coordination with the Renal Transplant Unit of Hospital Clinic de Barcelona (HCB), Spain. Absence of rejection mediated by isoagglutinins shows the potential benefit of a protocol consisting in removing antibodies from the anti-blood group. Two years after transplantation, the kidney function remains stable, with creatinine levels of 1.5 mg%. We conclude that an ABO-incompatible kidney transplant is a viable option for patients whose only donor has blood of an incompatible blood group and for us this represents a hope-inspiring source of organs. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-07-17 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222 10.15381/anales.v78i2.13222 |
url |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222 |
identifier_str_mv |
10.15381/anales.v78i2.13222 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/13222/12353 |
dc.rights.none.fl_str_mv |
Derechos de autor 2017 Pedro Méndez Chacón https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2017 Pedro Méndez Chacón https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
dc.source.none.fl_str_mv |
Anales de la Facultad de Medicina; Vol. 78 No. 2 (2017); 224-229 Anales de la Facultad de Medicina; Vol. 78 Núm. 2 (2017); 224-229 1609-9419 1025-5583 reponame:Revistas - Universidad Nacional Mayor de San Marcos instname:Universidad Nacional Mayor de San Marcos instacron:UNMSM |
instname_str |
Universidad Nacional Mayor de San Marcos |
instacron_str |
UNMSM |
institution |
UNMSM |
reponame_str |
Revistas - Universidad Nacional Mayor de San Marcos |
collection |
Revistas - Universidad Nacional Mayor de San Marcos |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1795238256196976640 |
score |
13.873571 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).